Results 41 to 50 of about 550,140 (248)
European Journal of Medical Research, 2016 Despite substantial advances in the imaging techniques and pathophysiological understanding over the last decades, identification of the underlying causes of left ventricular hypertrophy by means of echocardiographic examination remains a challenge in ...
Dan Liu +5 more
semanticscholar +1 more source
Majalah Kardiologi Indonesia, 2013 Background: Some research reports the usefulness of the N-terminal proBrain natriuretic peptide (NT proBNP) as a diagnostic tool for left ven-tricular hypertrophy due to increased levels of NT proBNP in hypertensive patients with left ventricular ...
Mohammad Ariful Munir, Djanggan Sargowo
doaj +1 more source
Left ventricular hypertrophy in renal failure [PDF]
Kidney International, 1998 In patients with terminal renal failure, left ventricular hypertrophy (LVH) is extremely common. It is found in approximately 60 to 80% of patients starting renal replacement therapy. The main causes of LVH are increased preload from hypervolemia and increased afterload from increased peripheral resistance, giving rise to a mixture of eccentric and ...
Kerstin Amann +3 more
openaire +4 more sources
Left ventricular hypertrophy diagnosed after a stroke: a case report
Journal of Medical Case Reports, 2018 Background Stroke is a recognized clinical course of hypertrophic cardiomyopathy. This interesting case showed notable difference on the electrocardiogram of a patient 4 months prior to suffering a stroke and 10 days after suffering a stroke.
Wilfred Ifeanyi Umeojiako, Ritesh Kanyal
doaj +1 more source
VALIDITY OF ELECTROCARDIOGRAPHIC VOLTAGE CRITERIA: HOW USEFUL ARE THEY IN ATHLETES? [PDF]
The Medical Journal of Basrah University, 2005 Electrocardiographic (ECG) criteria for left ventricular (LV) hypertrophy have been almost exclusively elaborated and calibrated in general population. Because several differences in ECG characteristics have been found in athletes, the applicability of ...
Laith A. Alrudainy +2 more
doaj +1 more source
Cardiac manifestations of PRKAG2 mutation. [PDF]
, 2018 BACKGROUND:The Protein Kinase AMP-Activated Non-Catalytic Subunit Gamma 2 (PRKAG2) cardiac syndrome is characterized by glycogen accumulation in the cardiac tissue.
Ardehali, Reza +3 more
core +1 more source
Journal of Cardiovascular Pharmacology, 1991 Long-lasting cardiac overload in man as well as in experimental animals leads to an increase in heart weight (or better: heart weight/body weight ratio). Cardiac hypertrophy can result from increased physiologic activity (“physiologic hypertrophy”) or from disease states (“pathologic hypertrophy”).
Reinhard G. Ketelhut, Franz H. Messerli
openaire +6 more sources
Association between noninvasive fibrosis markers and cardio-vascular organ damage among adults with hepatic steatosis [PDF]
, 2014 Evidence suggests that advanced fibrosis, as determined by the noninvasive NAFLD fibrosis score (NFS), is a predictor of cardiovascular mortality in individuals with ultrasonography-diagnosed NAFLD. Whether the severity of histology (i.e., fibrosis stage)
Fiorentino, Tv +5 more
core +6 more sources
Left ventricular hypertrophy: differential diagnosis
Ендоваскулярна нейрорентгенохірургія, 2020 There are some imaging methods for the diagnosis of left ventricular hypertrophy. Such as echocardiography, computed tomography, magnetic resonance imaging.
N.M. Nosenko +3 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022 Background Cardiomegaly caused by left ventricular hypertrophy is a risk factor for development of congestive heart failure, classically associated with decreased systolic and/or diastolic ventricular function.
Gautam K. Singh +6 more
doaj +1 more source